APA (7th ed.) Citation

Lanzoni, G., Linetsky, E., Correa, D., Messinger Cayetano, S., Alvarez, R. A., Kouroupis, D., . . . Ricordi, C. (2021). Umbilical cord mesenchymal stem cells for COVID‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, randomized controlled trial. Stem cells translational medicine, 10(5), 660-673. https://doi.org/10.1002/sctm.20-0472

Chicago Style (17th ed.) Citation

Lanzoni, Giacomo, et al. "Umbilical Cord Mesenchymal Stem Cells for COVID‐19 Acute Respiratory Distress Syndrome: A Double‐blind, Phase 1/2a, Randomized Controlled Trial." Stem Cells Translational Medicine 10, no. 5 (2021): 660-673. https://doi.org/10.1002/sctm.20-0472.

MLA (9th ed.) Citation

Lanzoni, Giacomo, et al. "Umbilical Cord Mesenchymal Stem Cells for COVID‐19 Acute Respiratory Distress Syndrome: A Double‐blind, Phase 1/2a, Randomized Controlled Trial." Stem Cells Translational Medicine, vol. 10, no. 5, 2021, pp. 660-673, https://doi.org/10.1002/sctm.20-0472.